BioCentury
ARTICLE | Clinical News

Thymosin alpha 1: Completed enrollment in its Phase III trial

May 3, 1993 7:00 AM UTC

Alpha 1 Biomedicals Inc. (ALBM) Product: Thymosin alpha 1 Indication: Chronic hepatitis B Status: Completed enrollment in its Phase III trial ...